Chugai Pharmaceutical Co., Ltd. (CHGCF) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - General उद्योग. कंपनी का मुख्यालय है Chuo, Japan. वर्तमान CEO हैं Osamu Okuda.
CHGCF के पास है IPO तिथि 2012-08-03, 5,026 पूर्णकालिक कर्मचारी, पर सूचीबद्ध Other OTC, बाजार पूंजीकरण $91.63B.
Chugai Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacture, and sale of medicines globally. The company maintains a diverse portfolio spanning oncology, immunology, hematology, ophthalmology, and other therapeutic areas, with established products including Tecentriq, Herceptin, Avastin, Rituxan, and Tamiflu. As a subsidiary of Roche Holding Ltd., Chugai leverages strategic alliances within the Roche Group and conducts collaborative research with academic institutions to advance its pipeline of development candidates. Founded in 1925 and headquartered in Chuo, Japan, the company continues to expand its international presence across multiple disease indications.
